Clinical Trial Update: Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol [NA]

View source ↗

Summary

Clinical trial update for the Impella ECP Study and Continued Access Protocol in patients undergoing high-risk percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Impella ECP

Snippet

Sponsor: Abiomed Inc. | Conditions: High-Risk Percutaneous Coronary Intervention | NA | Status: ENROLLING_BY_INVITATION